Medical discovery could save millions of lives
An international team of researchers has now made a major scientific breakthrough in the treatment of various cancers. The new discovery could have the potential to successfully treat millions of people with cancer in the future, saving the lives of so many.
Scientists from the Australian Walter and Eliza Hall Institute found that a newly discovered compound can effectively kill a protein that is responsible for cancer growth. The compound with the designation S63845 is designed for the targeted treatment of the protein MCL1. The doctors published the results of their study in the journal "Nature".
Targeted treatment can kill cancer cells
The MCL1 protein keeps cancer cells alive and has already been identified in a variety of cancers, the experts say. The inhibition of the protein is effective in targeting several different types of cancer. Targeted treatment of MLC1 basically kills the affected cancer cells completely, explains Professor Guillaume Lessene from the Walter and Eliza Hall Institute.
Treatment particularly effective for different types of blood cancer
This type of treatment has also been shown to be particularly effective in the fight against blood cancer. This type of cancer includes, for example, acute myeloid leukemia, lymphoma and multiple myeloma. All of these cancers are particularly sensitive to compound S63845, Professor Lessene adds. This finding is a major scientific breakthrough and it is now only a matter of time before the first clinical studies will begin, the authors explain.
Clinical trials should be started quickly
MCL1 is one of the most important pillars for cancer survival. Now we have found a way to weaken these cancer cells, the doctors say. In the near future, clinical trials on this topic should definitely be carried out. Ultimately, millions of cancer patients could benefit from this new drug, explains Dr. Wei.
S63845 is not only aimed at a certain type of cancer
MCL1 is widely used in a variety of cancers. For this reason, we literally have the opportunity to conduct clinical studies on a huge range of cancers, the scientists explain. The potential benefits of S63845 could help many cancer patients because, unlike some medications, they are not focused on a specific condition. (as)